ClinicalTrials.govpublic full text
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
metastatic castration-resistant prostate cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 363622
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.